CLINICAL_TRIALS
trial_result
· 2019-12-23
Clinical Trial Update: Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes [Phase 2]
Summary
Phase 2 safety and tolerability trial of MEDI0382 in Japanese preobese or obese subjects with Type 2 diabetes completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2019-12-23